Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Broadcom (NASDAQ: AVGO). To learn more, check ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...

Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...

Investing.com-- Google’s (NASDAQ: GOOGL) artificial intelligence research arm, DeepMind, has imposed stricter controls on the ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

The new policies include a six-month delay on some research papers and mandate several approval steps before publishing. This process slows down the researchers from sharing their work. Former ...

Gemini 2.5 Pro represents a significant step forward in AI model design, combining raw power with refined reasoning ...